سعر هيرباريل جل موضعي 40 جرام 2022

Topical gel (Pharco, Egypt) containing aescin and diethylamine salicylate, listed by Egyptian directories for contusions, sprains, bruises, haematoma, painful spinal conditions, superficial thrombophlebitis and varicose veins; 40 g.

• Contusions, crush injuries, sprains, bruises, haematoma and tenosynovitis; painful conditions of the vertebral column (disc lesions, neck pain, lumbago, sciatica); superficial thrombophlebitis and varicose veins; care of veins after injections or infusions (directory text).

• Very rare: dry skin, rash, erythema, dermatitis including contact dermatitis, pruritus, urticaria and scaling.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)

• Do not use in hypersensitivity to salicylates or aescin, to other pain and rheumatism medicines (NSAIDs), or to any other ingredient.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)
• Do not apply to open injuries, inflamed or infected skin, eczema, mucous membranes or irradiated skin areas.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)

• Patients with asthma, hay fever, nasal polyps, chronic obstructive airway disease or chronic respiratory infections, or with hypersensitivity to analgesics, are at higher risk of asthma attacks, local swelling (Quincke oedema) or urticaria.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)
• Keep away from the eyes; children should not touch treated skin. Not recommended in children under 12 years (insufficient data).General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)
• When applied to large skin areas, systemic adverse effects like those of oral salicylates cannot be excluded.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)

• No data on use in pregnant women; use during pregnancy is not recommended, and large-area application in particular should be avoided.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)
• It is not known whether the ingredients pass into breast milk; use during breastfeeding is not recommended and application to the breast area must be avoided.General active-ingredient information · Viatris Healthcare GmbH (package leaflet, Germany)

English text not available for this section.